Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion type Assertion NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_head.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion description "[However, the variant-containing genotypes (DI+II) of PGR (rs1042838) showed low risk in both GBC [OR = 0.4] and gallstone patients [OR = 0.4].On performing the MDR analysis, ESR1 IVS1-397C>T, ESR1 IVS1-351A>G, and ESR2-789 A>C yielded the highest testing accuracy of 0.634.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_provenance.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion evidence source_evidence_literature NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_provenance.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion SIO_000772 22808109 NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_provenance.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion wasDerivedFrom befree-20140225 NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_provenance.
- NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_assertion wasGeneratedBy ECO_0000203 NP542362.RAico5k_LFz8Kei9It13LoG8qgEDfTZhmqCnGVqSh-LAg130_provenance.